ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
Dow Jones
38.834,86
0,15%
Euro vs US Dollar
1,07449
-0,02%
Bitcoin
65.043,44
0,12%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Phoenix Biotech Aquisition Corporation (PBAXU)

  7. Phoenix Biotech Aquisition Corporation (PBAXU) News

PBAXU

Phoenix Biotech Aquisition (PBAXU)

Phoenix Biotech Aquisition Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PBAXU
DatumZeitQuelleÜberschriftSymbolFirma
05/06/202423h13Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
22/05/202414h00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/05/202423h09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
16/05/202412h28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
06/05/202423h11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/05/202406h16Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
01/05/202422h45Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
01/05/202422h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
26/04/202422h31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
15/04/202422h36Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
10/04/202422h06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
03/04/202423h27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202413h12Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202413h07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202403h54Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/03/202402h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/03/202402h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/02/202415h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
27/02/202414h27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
27/02/202403h37Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
23/02/202423h13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
20/02/202423h18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202401h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202401h29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202401h28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202418h14Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
14/02/202418h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
12/02/202422h16Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
12/02/202422h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:PBAXU

Kürzlich von Ihnen besucht

AMEX
GNB
DOWI
MSGR
BOV
SGPS3R
SPRINGS ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten